SUMMARY Paraffin embedded sections of human liver, lymph node, and placenta showed that certain connective tissue cells were positive for factor XIII subunit a. These cells were further characterised by double immunofluorescence labelling and by combined immunofluorescence and enzyme cytochemical staining on frozen sections. They were labelled by the monoclonal antibodies RFD7 and anti-Leu M3 (markers of the macrophage cell line) but gave a negative reaction for the fibroblast marker IIG1O and showed no alkaline phosphatase activity.
Factor XIII is a plasma pro-transglutaminase consisting of a and b subunits in a tetrameric structure (a2b2). During the process of blood coagulation activated factor XIII (a2) acts as a catalyst for the formation of isopeptide bonds between polymerising fibrin molecules. ' A cellular form of factor XIII consisting exclusively of a subunits has also been shown in platelets23 and monocytes,45 though the function of the intracellular factor is not fully known.
Data accumulated over the past two Accepted for publication 25 June 1987 factor XIII subunit a is retained during the differentiation of monocytes into macrophages.'I5
As histiocytes (tissue macrophages) belong to the mononuclear phagocyte system and are generally considered to be derived from circulating blood monocytes,'6 it seemed reasonable to us that connective tissue macrophages also express factor XIII subunit a. This hypothesis prompted us to reinvestigate the presence of factor XIII subunits in connective tissue cells and to attempt to characterise the cells expressing either of the factor XIII subunits.
Material and methods
Tissue sections examined included three histologically normal specimens of human liver, lymph node obtained at necropsy, and full term placenta. Tissue samples were divided into two parts: one part was fixed in 3-5% paraformaldehyde fixative for six hours and then vacuum embedded in paraffin; the other part was snap frozen. Sections (6 pm) were cut from both paraffin embedded and frozen blocks.
Human adult foreskin fibroblasts were cultivated according to Brown et al. '7 Cells at passage number 20 were harvested for the experiments. Human citrated venous blood was centrifuged at 400 g for 10 minutes at 20°C. Platelet rich plasma was 50 removed and pelleted (3000 g for 10 minutes at 4°C). The pellet was resuspended and washed twice in phosphate buffered saline (PBS), pH 7-4, containing 5 mmol/l ethylene-diaminotetra-acetic acid. Mixed placental suspension was prepared according to the method of Butterworth and Loke'8 with the exception that after a preliminary trypsin digestion for 10 minutes the suspension was filtered through three layers of gauze to remove syncytial cells. The denuded villi were further digested and the isolated cells were washed in PBS containing 5 mmol/l edetic acid. Macrophages were isolated from the mixed placental cell population by a separation technique for peripheral blood monocytes.'9 Viability and the phagocytic activity ofisolated cells were tested according to the method of Bevilacqua et al. 20 As a first step, factor XIII subunit a was detected by indirect immunofluorescence, as described above. After washing in distilled water the activity of alkaline phosphatase present in fibroblasts, but not in monocytes or macrophages26 was developed by 15 minutes of incubation at 37°C in naphtol AS-MX phosphate buffer27 containing I g/l fast red TR salt. The specificity of the enzyme cytochemical reaction for alkaline phosphatase was checked by the omission of substrate from the incubation medium. Slides were Characterisation ofconnective tissue cells containingfactor XIII subunit a mounted in 50% glycerol in PBS and examined by ultraviolet microscope on an FITC channel. Fields photographed at fluorescence excitation were rephotographed in normal light.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (10%) (SDS PAGE)2' and immunoblotting of denatured placental cell extract for factor XIII subunits were carried out as described previously. 4 The same procedure was used for fibroblasts and platelets, with the modifications that a 5-15% gradient gel was used in SDS PAGE and that 0-5% 4-chloro-l-naphtol was used as chromogen.
Results
Immunoperoxidase staining offactor XIII subunit a in sections of human liver and placenta gave patterns similar to those obtained earlier by Fear et al. ' 2 Briefly, liver cells labelled for factor XIII subunit a were localised in the connective tissue of the portal tract; Kupffer cells and hepatocytes were negative. In the placenta only certain mesenchymal cells were labelled for this antigen. In the lymph node some ofthe positive cells were found in the capsular connective tissue.
Other cells positive for factor XIII in the lymphoreticular tissue have already been characterised and the results published in a separate paper.28 Cells labelled for factor XIII subunit a appeared mainly as spindle-shaped, fibroblast-like elements in adult connective tissue, while a stellate morphological appearance was observed in mesenchymal cells.
IMMUNOMORPHOLOGICAL AND ENZYME CYTOCHEMICAL CHARACTERISATION OF CELLS POSITIVE FOR FACTOR XIII SUBUNIT A On frozen sections of full term placenta, mesenchymal cells containing factor XIII subunit a were almost equally positive for both RFD7 (fig 1) and Leu M3 ( fig  2) . After simultaneous detection offactor XIII subunit a and IIG10, a surface marker of fibroblasts, no double labelled cells were observed in the mesenchyme (fig 3) . Similar results were obtained on frozen sections of liver and lymph node by using the same double labelling systems that is, cells positive for factor XIII subunit a also stained for Leu M3 and RFD7 (data not shown), but not for IIGIO. When the detection of alkaline phosphatase activity was combined with the Characterisation of connective tissue cells containingfactor XIII subunit a immunofluorescence reaction for factor XIII subunit a, the two reactions labelled different cell populations (fig 4) . The only difference in the marker reactions of cells containing factor XIII subunit a in the mesenchymal tissue of placenta and in adult connective tissue of lymph node and liver was the different expression of HLA-DR antigen. Cells positive for factor XIII of adult connective tissue were strongly positive for HLA-DR (fig 5) , while those cells of mesenchyme were negative or only weakly positive (data not shown). The results obtained by double immunofluorescence are summarised in the table.
DETECTION OF FACTOR XIII SUBUNIT A BY IMMUNOBLOTTING
The absence of factor XIII subunit a in human fibroblasts and its presence in placental macrophages was clearly shown by immunoblotting (figs 6 and 7). About 70% of mesenchymal macrophages isolated from human placenta stained for factor XIII subunits a and b. After immunoblotting with a nitrocellulose sheet of placental cell proteins and resolution on 10% SDS-PAGE, a single protein band comigrating with subunit a of factor XIII could be detected by antiserum against subunit a (fig 7) . In a separate experiment no protein band of fibroblast extract was stained by the same antibody (fig 6) .
SUBUNIT B OF FACTOR XIII IN CONNECTIVE TISSUE CELLS
The cell population labelled for factor XIII subunit a by immunoperoxidase and immunofluorescence techniques was also stained by the commercially available antiserum against the b subunit, though a stronger antiserum was required to obtain a positive reaction. The antiserum against the b subunit cross reacted with the a subunit of purified factor XIII and of factor XIII present in placental macrophages (fig 7) .
Discussion
Recently Fear et al reported that certain cells in the connective tissue contained both a and b subunits of factor XIII, and they presumed that these cells were inactive fibroblasts.'2 In a subsequent paper from the same laboratory, both factor XIII subunits were 4 .W* In the former study, however, the specificity of the antibody was not checked, thus a cross reaction with the a subunit can not be excluded. In our study this problem was dealt with by immunoblotting. The two subunits of factor XIII have different mobility in 10% SDS-PAGE, and after electroblotting the separated protein bands a clear distinction can be made between a and b subunits. In this system the antiserum against the b subunit showed a clearly detectable cross reaction with subunit a. It was also clearly shown that placental macrophages which gave a positive immunomorphological reaction were indeed devoid of subunit b. Though trypsinisation used for the separation of placental macrophages may destroy surface antigens, the staining obtained by the antiserum against subunit b showed intracellular localisation-that is, the antigen detected by it is in all probability inaccessible to the proteolytic enzyme. Furthermore, even if the b subunit had been present but had been degraded by trypsin, lower molecular weight split products should have been picked up in the blotting system by the polyclonal antibody.
In conclusion, our findings strongly suggest that connective tissue macrophages contain subunit a, but not subunit b of factor XIII; the positive immunomorphological reaction for the latter was due to the cross reaction of antiserum used. This finding agrees with Bohn's earlier results, which showed the absence of subunit b in placental extract. 35 As far as the role of factor XIII in macrophages in the formation of connective tissue matrix and in wound healing is concerned, only hypotheses can be postulated.
In their study of the role of the monocyte/macrophage cell line in wound repair, Leibovich and Ross36 found that macrophage depletion during wound healing resulted in considerable delay in fibroblast proliferation. They hypothesised that macrophages promote fibroblast proliferation through the production of a factor (or factors). Factor XIII in tissue macrophages might be one such factor. Further investigations on this subject may contribute to a better understanding of connective tissue homeostasis and pathological changes in scar formation.
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